MRI represents a powerful imaging modality leveraged by neuroradiologists for screening, diagnosing, and monitoring various neurological conditions. Understanding advances and trends in neuro MRI, along with their potential impact on clinical practice, is essential for these professionals. In an effort to provide the neuroradiology community with the most up-to-date information, this symposium will cover updates and trends on the use of GBCAs in MR imaging, focusing on the impact of AI on the routine use of GBCAs and how best to optimize GBCA in clinical practice balancing retention and efficacy.
- Understand recent advances and trends as it relates to contrast use.
- Discuss how AI can be leveraged in neuro MR exams to reduce the dose of GBCAs while maintaining diagnostic quality.
- Discuss how to balance retention and efficacy in today’s clinical MRI practice.
The content of this CME/CE Symposium is intended for healthcare professionals including Radiologists and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, Technologists and Others.
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 1.0. AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Valid from 06/11/2020 – 06/11/2021
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.
David S. Enterline, MD, FACR
- Bracco Diagnostics Inc. – Consultant
- Merit Medical, Inc. – Consultant
Matthew J. Kuhn, MD, FACR
- No relevant financial disclosures – Investigational use only
Audio of Q&A Session